NY A10095

Requires gene synthesis providers and manufacturers of gene synthesis equipment in New York to operate according to international gene synthesis consortium protocols.

Mandates screening of all synthetic gene orders against regulated pathogen databases including federal HHS and USDA select agents lists, Australia Group pathogens, and international sequence databanks (NCBI/GenBank, EBI/EMBL, DDBJ).

Requires customer identification data (shipping address, institution name, country, telephone, email) and screening against federal sanctions lists, debarred persons lists, and denied persons lists before fulfilling orders.

Establishes enhanced screening requirements for regulated pathogen sequences, including written descriptions of intended use and independent verification of customer identity and legitimacy for government labs, universities, non-profits, and industrial research facilities.

Requires eight-year record retention of all synthesized genes, screening results, recipient identity, and shipping addresses; prohibits sales to distributors or resellers unless end-users are identified and verified for compliance.